Stay updated with breaking news from Altor Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DUBLIN--(BUSINESS WIRE)--The "Cancer Vaccines Global Market Report 2022: By Type, By Technology, By Cancer, By End-User" report has been added to ResearchAndMarkets.com's offering.The global cancer vaccines market is expected to grow from $4.47 billion in 2021 to $5.29 billion in 2022 at a compound annual growth rat...
A blood test to detect circulating tumor DNA accurately predicted recurrence of HPV-driven oropharyngeal cancer after treatment, according to research presented at Multidisciplinary Head and Neck Cancers Symposium.In addition, findings from the retrospective clinical case series suggested the biomarker test may detect disease recurrence earlier than imaging or other surveillance methods, allowing
Non–Muscle-Invasive Bladder Cancer (NMIBC) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2020 To 20
Non–Muscle-Invasive Bladder Cancer (NMIBC) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2020 To 20
Sotio Biotech has advanced its effort to become a major player in the solid tumor space. Days after raising $316 million, Sotio has unveiled a deal with Merck to use Keytruda in a clinical trial that is central to its plans for investing in the megaround.